Kapil D. Sethi

Best Publications

• The scientific and clinical basis for the treatment of Parkinson disease (2009)

  C. Warren Olanow;Matthew B. Stern;Kapil Sethi

  1218
  Citations

• The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

  Kallol Ray Chaudhuri;Pablo Martinez-Martin;Richard G. Brown;Kapil Sethi

  1201
  Citations

• SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

  Irene Litvan;Kailash P. Bhatia;David J. Burn;Christopher G. Goetz

  1065
  Citations

• Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients

  Pablo Martinez-Martin;Anthony H.V. Schapira;Fabrizio Stocchi;Kapil Sethi

  694
  Citations

• The Nondeclaration of Nonmotor Symptoms of Parkinson's Disease to Health Care Professionals: An International Study Using the Nonmotor Symptoms Questionnaire

  K. Ray Chaudhuri;Cristina Prieto-Jurcynska;Yogini Naidu;Tanya Mitra

  483
  Citations

• The role of radiotracer imaging in Parkinson disease

  B. Ravina;D. Eidelberg;J. E. Ahlskog;R. L. Albin

  385
  Citations

• Ropinirole for the treatment of early Parkinson's disease

  C. H. Adler;K. D. Sethi;R. A. Hauser;T. L. Davis

  364
  Citations

• A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit

  M Flint Beal;David Oakes;Ira Shoulson

  344
  Citations

• Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12-week, double-blind, randomized, parallel-group, placebo-controlled study

  Arthur S Walters;William G Ondo;Tilman Dreykluft;Ron Grunstein

  322
  Citations

• International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.

  P. Martinez-Martin;C. Rodriguez-Blazquez;K. Abe;K. B. Bhattacharyya;K. B. Bhattacharyya

  312
  Citations

• Nonmotor Manifestations of Parkinson's Disease

  Tatyana Simuni;Kapil Sethi

  295
  Citations

• A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor

  M. F. Brin;K. E. Lyons;J. Doucette;C. H. Adler

  289
  Citations

• Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.

  Mark Stacy;Annette Bowron;Mark Guttman;Robert Hauser

  282
  Citations

• A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease

  Abraham N. Lieberman;C. W. Olanow;K. Sethi;P. Swanson

  270
  Citations

• Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations.

  K. D. Sethi;R. J. Adams;D. W. Loring;T. El Gammal

  266
  Citations

• Reliability of a new scale for essential tremor

  Rodger Elble;Cynthia Comella;Stanley Fahn;Mark Hallett

  259
  Citations

• Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

  Robert A. Hauser;Ann Hsu;Sherron Kell;Alberto J. Espay

  250
  Citations

• Levodopa Unresponsive Symptoms in Parkinson Disease

  Kapil Sethi

  211
  Citations

• Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study.

  Cheryl H. Waters;Kapil D. Sethi;Robert A. Hauser;Eric Molho

  209
  Citations

• Drug-induced tremors

  John Christopher Morgan;John Christopher Morgan;Kapil D. Sethi

  204
  Citations